{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P04792",
      "entity_text" : "Hsp27",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Inhibition of the expression of Hsp27 with siRNA or OGX-427, an antisense oligonucleotide in phase II trials, synergistically enhanced the efficacy of EGFR tyrosine kinase inhibitor XREF_BIBR, radiation XREF_BIBR, Hsp90 inhibitor XREF_BIBR, MET inhibitor XREF_BIBR, paclitaxel XREF_BIBR.",
  "reading_complete" : "2020-08-03T09:40:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:39:48Z",
  "trigger" : "enhanced",
  "evidence" : [ "Hsp27 with siRNA or OGX-427, an antisense oligonucleotide in phase II trials, synergistically enhanced the efficacy of EGFR" ],
  "pmc_id" : "4775865",
  "score" : 0
}